Dalan selected as finalist to pitch at the upcoming Animal Health Innovation Europe conference

The humble bee — the world’s greatest pollinator — is in trouble. Dalan has the solution.

INTRODUCING

The world’s first bee vaccine platform

Beehives in a bright yellow rapeseed field

With annual U.S. revenue estimated to be $1 billion, commercial beekeeping is a significant market.

But 30-45% of hives are lost annually, with many bees succumbing to highly contagious and devastating diseases.

Why bee health matters

The Industry

$10 billion

Expected global apiculture market by 2023

$1 billion

Annual revenue across 2 million commercial hives in the U.S.

50%

Number of hives where AFB bacteria spores are present

Dalan’s unique insect vaccine technology has the potential to reduce the severity of honeybee infectious diseases such as American Foulbrood.

Reference

More about the science

dalan in the press

“We are on borrowed time if we do not have a prophylactic. Probiotics are good, but are a Band-Aid solution. We must decrease vulnerability and protect supply — we are at the critical edge…”